Two Sigma Advisers
ALNA

Two Sigma Advisers’s Allena Pharmaceuticals ALNA Stock Holding History

Two Sigma Advisers’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-137,900
Closed -$192K – 2783
2021
Q1 		$192K Buy
+137,900
New +$230K ﹤0.01% 2359

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers's ALNA Position: Q2 2021 in Review

Two Sigma Advisers sold out of Allena Pharmaceuticals (ALNA) in Q2 2021, closing a stake of 137,900 shares — an estimated $192K sold.

Two Sigma Advisers first reported a position in ALNA in Q1 2021 and held it in 1 quarter. The position peaked at $192K in Q1 2021. 29 funds tracked by Wall St. Rank hold ALNA as of Q2 2021.

  • Two Sigma Advisers reported no remaining Allena Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 137,900 Allena Pharmaceuticals shares in Q2 2021, an estimated $192K.
  • Two Sigma Advisers first reported a position in Allena Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Two Sigma Advisers's Allena Pharmaceuticals position peaked at $192K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2021.

Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.